Amgen Inc.

AMGN · CIK 0000318154

19 fiscal years · 70 SEC filings · every number carries its receipt

Revenue (FY)

$36.75B10.0%

FY2025

Net income (FY)

$7.71B88.5%

FY2025

Free cash flow (FY)

$8.10B22.1%

FY2025

Diluted EPS (FY)

$14.2388.2%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 2.5× since FY2007 · net margin 20.8% → 21.0%

MarginsNet marginFCF margin

FY2025: net 21.0% · free cash flow 22.0% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $9.96B operating cash − $1.86B capex = $8.10B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 19% (FY2008) → 89% (FY2025) · on assets 8.5%

The receipts

Amgen Inc.

AMGN · CIK 0000318154

19 fiscal years · 70 SEC filings · every number carries its receipt

Revenue (FY)

$36.75B10.0%

FY2025

Net income (FY)

$7.71B88.5%

FY2025

Free cash flow (FY)

$8.10B22.1%

FY2025

Diluted EPS (FY)

$14.2388.2%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 2.5× since FY2007 · net margin 20.8% → 21.0%

MarginsNet marginFCF margin

FY2025: net 21.0% · free cash flow 22.0% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $9.96B operating cash − $1.86B capex = $8.10B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 19% (FY2008) → 89% (FY2025) · on assets 8.5%

The receipts